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Variant callAdvances innext-generation sequencing (NGS) technologies have greatly improvedour ability to detect genomic
variants for biomedical research. The advance in NGS technologies has also created signiﬁcant challenges in
bioinformatics. One of the major challenges is the quality control of sequencing data. There has been heavy
focus on performing raw data quality control. In order to correctly interpret the quality of the DNA sequencing
data, however, proper quality control should be conducted at all stages of DNA sequencing data analysis: raw
data, alignment, and variant detection.We designed QC3, a quality control tool aimed at those threemajor stages
of DNA sequencing. QC3 monitors quality control metrics at each stage of NGS data and provides unique and
independent evaluations of the data quality from different perspectives. QC3 offers unique features such as
detection of batch effect and cross contamination. QC3 and its source code are freely downloadable at https://
github.com/slzhao/QC3.
© 2014 Elsevier Inc. All rights reserved.1. Introduction
High throughput sequencing is the most effective way to screen for
non-speciﬁc germline variants, somatic mutations, and structural
variants. Some of the most popular sequencing paradigms in DNA
sequencing are exome sequencing, whole genome sequencing, and
target panel sequencing. While vastly informative, sequencing data
poses signiﬁcant bioinformatics challenges in areas such as data storage,
computation time, and variant detection accuracy. One of the easily
overlooked challenges associated with sequencing is quality control.
Quality control for DNA sequencing data can be categorized into three
stages: raw data, alignment, and variant calling [1]. One of the major
misconceptions of DNA sequencing quality control is that quality con-
trol is only needed at the raw data stage. QC on raw sequencing data
has been givenmore attention thanQCon alignment and variant calling,
and this is also reﬂected in the number of tools developed for raw data
QC versus alignment and variant calling. Raw data QC tools include
FastQC [2], FastQ Screen [3], FASTX-Toolkit [4], NGS QC Toolkit [5],
RRINSEQ [6] and QC-Chain [7]. In contrast, fewer tools have beenilin.zhao@vanderbilt.edu
e@vanderbilt.edu (F. Ye),
ilt.edu (B. Lehmann),
chgr.mc.vanderbilt.edudeveloped for conducting quality control on alignment and variant call-
ing despite the fact that quality control is essential at all three stages of
DNA sequencing data processing. Several notable alignment QC tools
are SAMStat [8], and GATK's QC measures [9]. SAMStat focuses on
reads mapping statistics such as distribution of mismatches and inser-
tions. When representing mapping statistics, SAMStat uses a pie chart
which arbitrarily divides reads by map quality score. In our approaches,
we use a distribution plot which does not arbitrarily stratify reads.
GATK's QC measures contain a series of independent scripts and tools
for various purposes. The disadvantage would be running GATK multi-
ple times in order to get complete QC results and GATK's results are
hardly interpretable for people with less experience. At the raw data
stage, quality control serves as a quick screening for data with serious
quality issues resulting from the sequencer, ﬂagging those data with
questionable quality. Quality control at the alignment stage focuses on
alignment quality, which is crucial for successful variant detection.
Quality control at the variant calling stage is the last chance to identify
samples with quality issues that slipped through quality control at ear-
lier stages and to further reduce the number of false-positive variants.
We have previously detailed three-stage QC strategies in Brieﬁngs in
Bioinformatics. Here, we present the actual implementation of these
strategies in a single package: QC3, a quality control tool for all three
stages of DNA sequencing data processing. QC3 provides both graphic
and tabulated reports for quality control results. It also offers several
unique features such as separation of good and bad quality reads
(based on Illumina's ﬁlter) and the detection of batch effects and cross
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FASTQ [10], Binary AlignmentMap (BAM) [11], and Variant Calling For-
mat (VCF), corresponding to the three stages of raw data, alignment,
and variant detection respectively. The overview of the concept behind
QC3 is shown in Fig. 1. QC3 iswrittenwith the combination of Perl andR
and is freely available for public use. QC3 can be conﬁgured to run in se-
ries or parallel. We recommend running the complete QC in sequential
order of the sequencing analysis. If needed, however, QC3 can perform
the QC checks individually at each stage. QC3 can provide results with
a reasonable time for processing. For Example, on a Linux machine
with a single core CPU at 2.8 Ghz speed and 8 GBmemory, QC3 can pro-
cess a standard sequencing dataset (30–50 million pair-end reads) in
around 20min at each stage with some variation depending on ﬁle size.2. Materials and methods
2.1. Raw data
Sequencing data analysis depends on raw data quality control for
informative results, and there are many publicly available tools that
suit this need. Investigators need to be aware of several considerations
regarding these quality control parameters. The ﬁrst is the Phred scale
used to measure base quality. The standard scale is Phred +33 (ASCII
0 to 62), but older Illumina pipelines (before Casava 1.3) used Phred
+64 (ASCII 59 to 126). Misidentifying the Phred scale [12,13]will result
in errors. Correctly scaled data will have a median base quality score
between 35 and 40 [14] for Illumina-generated data, and the shape of
a base quality vs. cycle plot should be the same regardless of Phred
scale. The second consideration is the nucleotide distribution across
sequencing cycles. Ideally, four nucleotides should have a stable distri-
bution across all reads, although there may be some ﬂuctuation at the
ends of reads or on the beginning cycles on some platforms. Nucleotide
distribution is closely related to base quality, and anunstable nucleotide
distribution will often accompany poor base quality. Both are good
indicators of raw data quality. The third consideration is GC content.
While the percentage of GC content varies across species and genomic
regions, a signiﬁcant deviation (over 10%) from the expected range of
the sample may indicate contamination. For raw data quality control,
QC3 offers similar functionality as the existing tools which check baseFig. 1. The quality control squality distribution by cycle visualized by a Q-score vs. cycle plot,
nucleotide distribution by cycle, and GC content.
An important feature that distinguishes QC3 from other QC tools
is that QC3 performs data quality assessment by separating the low-
quality reads from the high-quality reads. Low-quality reads are denot-
ed with the letter “Y” in the 9th ﬁeld in each read's description row,
which is contained in all FASTQ data generated by Illumina Casava
1.8+. Since the majority of current DNA sequencing data is paired-
end, differences between read 1 and read 2 can provide information
about read quality. Due to reasons such as phasing/pre-phasing,
decreased signal to noise ratio, and template damage over many cycles
of laser imaging, the second read sometimes has signiﬁcantly worse
quality than the ﬁrst read. QC3 takes both types of reads into account
and, can detect discrepancies by calculating Pearson's correlation and
Euclidean distance between the base quality scores of the two reads.
Signiﬁcantly different base quality distribution between the read pair
would indicate quality issue.
Quality control on raw sequencing data provides quick insight into
sample quality and can potentially save a signiﬁcant amount of time
in later analysis by allowing early identiﬁcation of questionable
samples. Passing quality control at the raw data level, however, does
not necessarily mean that a sample is free from quality issues. Nor
does questionable quality within a sample mean that the sample is
necessarily useless for subsequent analysis. For example, a portion of
reads in a sample can be bad, causing the sample to fail the raw data
quality control checks, but after removing those bad reads, a sufﬁcient
number of good quality reads may still be present to allow further
meaningful analysis to be carried out. Raw data quality control is
necessary and informative, but one cannot determine the sample
quality solely based on the raw data quality control results.
2.2. Alignment
Alignment is a non-optional step for any re-sequencing analysis.
Quality control on the alignment provides additional insights into
sample quality and can help identify bad samples that slip through the
rawdata quality control checks. Despite this, quality control of the align-
ment stage is not formally included in many sequencing data analysis
pipelines and is not performed on a regular basis. For exome sequenc-
ing, one of the most important QC parameter is the capture efﬁciency,trategies behind QC3.
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total number of reads after some quality ﬁlter. Capture efﬁciency is
highly dependent on the capture kit. For exome sequencing, there are
three major exome sequencing capture kits on the market: Illumina
TrueSeq, Agilent SureSelect, and NimbleGen SeqCap EZ. The capture
regions for the exome capture kits range from 37.6 to 62.1 million
base pairs. Other capture techniques available include array-based and
selector probe-based methods. Previous studies have shown that cap-
ture efﬁciencies between 40 and 70% are typical for exome sequencing
[14–17]. Lower capture efﬁciencies can indicate low complexity in the
target library, sub-optimal probe hybridization conditions, or low
stringency washes post-capture. QC3 evaluates capture efﬁciency if
the capture kit's BED ﬁle is provided. Otherwise, QC3 uses the standard
exome annotation ﬁle from RefSeq to deﬁne the exome regions as
capture regions.
Furthermore, it has been shown that reads aligned in intron and
intergenic regions can generate high-quality data [17], and mitochon-
dria genome sequence can be extracted from exome sequencing data
[18]. Thus, we designed QC3 to separate reads into several different cat-
egories (on target, intronic, intergenic, mitochondrial, and unmapped)
and to compute quality control parameters such as the median and
meanmapping quality, insert size, and depth for each category. Median
depth is not calculated by default due to the long computation time
required, but the user can choose to run the calculation. As informativeFig. 2.A. Distribution of read count by lane identiﬁes lane 7 as a clear outlier. Lane 7 contains sam
for sample 37 fails to detect sample 37 as an outlier. C. Nucleotide distribution by cycle plot for sa
on lane 8 have a slightly lower GC content, causing us to ﬂag these samples.as quality control on alignment can be, contaminated samplesmight not
be detectable in this stage.
2.3. SNP detection
For themajority of exome sequencing studies, detecting SNPs is one
of the pivotal steps leading toward the ﬁnal conclusion of the study.
Quality control on SNP calls will not only help identify bad samples
that have passed through the raw data and alignment quality control
checks but will also minimize the rate of false positive SNP calls.
QC3 uses several important criteria for evaluating SNP calls, includ-
ing the transition/transversion (Ti/Tv) ratio and the heterozygosity to
non-reference homozygosity ratio (het/non-ref-hom). The Ti/Tv ratio
has been used bymultiple studies [18,19] as a quality control parameter
for assessing the overall SNP quality. The Ti/Tv ratio is computed as the
number of transition SNPs divided by the number of transversion SNPs.
Even though the number of possible transversions is twice as many as
the number of possible transitions, leading to a Ti/Tv ratio of 0.5 if mu-
tations occurred at equal rates, the actual Ti/Tv ratio differs by genomic
regions. The Ti/Tv ratio is around 3.0 for SNPs inside exons and about 2.0
elsewhere [14,20], and the ratio also differs between synonymous and
non-synonymous SNPs [21]. Because the target regions of exome cap-
ture kits often covermore than just exons, the Ti/Tv ratio for SNPs inside
these target regions is expected to lie between 2.0 and 3.0 with theple 37,whichwas later determined to have failed sequencing. B. Base quality by cycle plot
mple 37 does not detect sample 37 as an outlier. D. GC content by lane shows that samples
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ratios in exome sequencing below the 2–3 range may be cause for con-
cern. The het/non-ref-hom ratio is another good quality control param-
eter for DNA sequencing data. We have mathematically proved that for
whole genome sequencing data het/non-ref-hom ratio is 2.0 based on
the Hardy–Weinberg equilibrium [1]. For exome regions het/non-ref-
hom would be signiﬁcantly lower.
QC3 also checks the number of non-synonymous SNPs. In 2009,
Bamshad et al. [22] showed that about 200 novel nonsynonymous
SNPs should be expected per person through exome sequencing when
compared to dbSNP 131. Themost updated dbSNP version 137 contains
72,952,578 additional SNPs, a 63% increase compared to version 131.
Thus, the number of novel nonsynonymous SNPs should be less than
what Bamshad et al. reported in 2009. An excessive number of novel
nonsynonymous SNPs detected would raise a quality control concern.
QC3 performs annotation against dbSNP 137 and reports novel
non-synonymous SNPs by sample using the ANNOVAR tool [23].
QC3 is capable of detecting cross-contamination of samples, which
can slip through the raw data and alignment quality control checks
without drawing any attention. Cross-contamination happens when
the DNA of different samples are accidentally mixed. QC3 detects such
problematic samples by computing the genotype consistencies between
all possible sample pairs. Three different types of genotype consistency
are computed: 1) heterozygous consistency using sample 1 in the pair
as denominator; 2) heterozygous consistency using sample 2 in the
pair as denominator, and 3) overall consistency including both hetero-
zygous and homozygous genotypes. The genotype consistency checkingFig. 3.A. Number of aligned reads by sample identiﬁes sample 37 as an outlier again. B. Average
46, causing us to ﬂag it. C. Mean insert size distribution. D. Mean depth distribution.is similar to the idea of computing identity by descent (IBD) in a genetic
study. Excessive heterozygous consistency between two random sam-
ples indicates cross contamination, or unknown relatedness between
the samples. Because majority of the human genome is homozygous,
the overall consistency should be much higher than heterozygous
consistency. Low heterozygous or overall consistency between known
related samples can indicate pedigree error or other contamination.
Additionally QC3 is able to estimate gender. Gender is estimated
from two perspectives: read count in Y chromosome and proportion
of heterozygous SNPs in X chromosome. Females do not have the Y
chromosome. Thus, for a female, the reads aligned to Y chromosome
should be signiﬁcantly less than that of a male. Some reads may still
align to Y chromosome due to homologous regions. Males have two X
chromosomes. Thus, all SNPs on X chromosome should be homozygous.
Excessive heterozygous SNPs on the X chromosome indicate the sample
is from a female host. By examining both read count on Y chromosome
and the proportion of heterozygous SNPs on X chromosome, we can
make a reasonably accurate inference on gender.
2.4. Batch effect detection
Batch effects are systematic technical variations in data caused by
processing data in batches. It can cause a complication during data
analysis especially for a large dataset. The Cancer Genome Atlas
(TCGA), one of the largest public available datasets also documented
the evidence of batch effect. The most common sequencing failures
often occur non-randomly, by lane, ﬂow cell, run, or machine. QC3mapping quality (MQ) based on BWA alignment shows a slightly lower average for sample
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ID of an experiment from either the FASTQ ﬁle or BAM ﬁles. Based on
this information, QC3 determines whether a batch effect exists using a
nonparametric Kruskal–Wallis [24] test and a Fligner–Killeen test of
homogeneity of variances [25] on the QC parameters (read count,
mapping quality, base quality, and capture efﬁciency).
3. Results
To demonstrate the effectiveness of QC3, we performed three-stage
quality control using QC3 on a breast cancer exome sequencing study.
This study contains a total of 30 breast tumor samples. The exomes
were captured using Illumina's TrueSeq capture kit and the libraries
were sequenced on a HiSeq 2000 platform. The reads are 75 base-
pairs long and with a pair-end.
We ﬁrst performed the raw data quality control on the raw data of
the 30 samples using QC3. Immediately, we noticed that sample 37
had only 14,353 reads, which clearly indicated failed sequencing.
Interestingly, sample 37was not picked up on the base sequence quality
plot or nucleotide distribution plot, whichmost raw data quality controlFig. 4. A. Heatmap displays pair-wise sample heterozygous genotype consistency using the ﬁ
contamination between samples 10 and 14, and samples 39 and 40. B. Heatmap matrix displa
pair as a denominator. C. Overall pair wise consistency which is computed as the number of co
for both samples.programs draw (Figs. 2B,C). By checking the batch effect, the low read
count of sample 37 also skewed the read count distribution of lane 7,
which was captured by the Fligner test (p-value b 0.001) (Fig. 2A
TotalReadsByLane). Other interesting ﬁndings from the batch effect
test were relatively lower GC content and base quality for samples on
lane 8 (Fig. 2D). These results prompted us to re-sequence sample 37
and ﬂag samples run on lane 8. For demonstration purposes, we includ-
ed the failed sample 37 for the later quality control steps. The tabular
report of raw data quality control can be viewed in Table S1.
After raw data quality control, we performed alignment using
BWA [26] and performed alignment quality control on the aligned
BAM ﬁles. Unsurprisingly, sample 37 was picked out as the obvious
outlier (Fig. 3A). In addition, sample 46 showed lower mean
mapping quality, which caused us to ﬂag it (Fig. 3B). Furthermore,
we did not detect any abnormal behavior on alignment statistics
for the ﬂagged samples on lane 8. The complete tabular report can
be found in Table S2.
SNPs were called using GATK's Uniﬁed Genotyper [9]. The VCF ﬁles
were quality controlled by QC3. The Ti/Tv ratio and heterozygous/non-
reference homozygous ratio of all samples appear normal even forrst sample in the pair as a denominator. Pairwise comparison identiﬁes possible cross-
ys pair-wise sample heterozygous genotype consistency using the second sample in the
nsistent genotypes divided by the number of total shared positions with genotypes called
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too few to be considered a successful sequencing, the few reads that did
get sequenced produced a few hundred reliable SNPs. Through contami-
nation analysis, we found possible cross-contamination between samples
10 and 14, and samples 39 and 40 (Figs. 4A,B). The heterozygous consis-
tency rate of 0.91 and 0.99 were observed between these two pairs of
samples respectively. The normal heterozygous consistency rate between
two unrelated samples should be around 0.2 to 0.3. Also sample 43
showed high heterozygous consistencies with multiple samples which
also indicate possible contamination. No outliers were observed for the
samples run on lane 8, despite observing slight abnormalities for these
samples during raw data quality control. Therefore we conclude that
these samples are useable. The complete tabular report of contamination
can be found in Table S4. QC3 organized the ﬁgures and tables into a
HTML ﬁle for better readability. The ﬁgures and tables presented here
only represent a partial output of QC3's results.
A second example was run using exome sequencing data from 11
TCGA breast cancer samples. TCGAdata has been through rigorous qual-
ity control before releasing to the public. Thus, it would generally not
have any quality issue. The samples were chosen randomly without
any bias. Out of the 11 samples, 10 are from tumor tissue, and the
11th was a blood sample from the same individual already presented
in the previous 10. The reason to pick the 11th sample from the same in-
dividual was to artiﬁcially create a situation where two samples have a
very similar heterozygous SNP consistencywhich resembles the scenar-
io of cross contamination. As expected, raw data and alignment QC on
this dataset showed great quality. However by running VCF QC, we
successfully identiﬁed that two samples are closely related through
their high heterozygous SNP consistency rate. This example once
again demonstrates that QC on raw data and alignment do not identify
cross contamination problems. The complete QC report of raw data,
alignment, VCF and information on the TCGA sample's barcode can be
viewed at https://github.com/slzhao/QC3.4. Discussion
Illumina's sequencing platform has dominated the sequencing
market for the last few years with no sign of diminishing. Thus, we de-
veloped our tool based on the Illumina sequencing platform. However,
the general concepts discussed here are applicable across a range of se-
quencing platforms, with appropriate modiﬁcations where necessary.
QC3 is designed with a large sample size in mind. Although it works
with single samples in general, some of its features such as detection
of contamination and batch effect are only appropriate for large sample
size studies.
As we have demonstrated, QC3 performs quality control at three
different stages and from different perspectives. It is essential that
we do not make hasty decisions based on the quality control results
from just a single perspective. Evaluating high throughput data
quality from the perspectives of raw data, alignment, and variant
calling allows researchers to identify problematic samples with
greater conﬁdence.
Even with the most rigorous quality control protocol, there are still
certain false positive results that can evade our quality control efforts.
For high impact studies, the use of additional methods such as RT-PCR,
Sequenom, or Sanger sequencing to validate the ﬁndings independently
from NGS sequencing is highly recommended.5. Availability
The source code, instruction manual and examples used in the
manuscript of QC3 can be accessed at https://github.com/slzhao/QC3.
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